Group 1 - The core viewpoint of the report is to provide a comprehensive analysis of the Chinese health technology industry landscape and competitive dynamics, along with forward-looking predictions for future trends [1] - The report highlights the participation of over 100 companies in the inaugural Health Tech 50 initiative from April 2024 to the present, showcasing the collaborative effort in evaluating outstanding enterprises [1] - The report categorizes the health technology industry into upstream, midstream, and downstream segments, focusing on areas such as nucleic acid drugs, synthetic biology, medical robots, and medical large models [1] Group 2 - AI and robotics technology applications in healthcare have expanded from auxiliary diagnosis to treatment planning, telemedicine, pathological diagnosis, and sleep respiratory health, driving the digital and intelligent transformation of the medical industry [2] - The rapid development of large models has shifted the Chinese health technology industry from a traditional AI framework to a model that supports various scenarios, enhancing the overall healthcare process from passive to proactive [2] - Large model technology is integrating into various medical and life science scenarios, reconstructing traditional medical software systems and creating innovative opportunities through its generalized capabilities [2]
以科技创新引领新质生产力发展 毕马威中国发布《首届健康科技50》报告
Zheng Quan Ri Bao Wang·2025-07-03 04:51